In vitro activity of sulbactam/durlobactam against global isolates of carbapenem-resistant Acinetobacter baumannii

In vitro activity of sulbactam-durlobactam against Acinetobacter baumannii-calcoaceticus complex isolates collected globally from 2016-2017

(2020) Sarah M. McLeod et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Antimicrobial Susceptibility of Acinetobacter calcoaceticus–Acinetobacter baumannii Complex and Stenotrophomonas maltophilia Clinical Isolates: Results From the SENTRY Antimicrobial Surveillance Program (1997–2016)

(2019) Ana C Gales et al.   Open Forum Infectious Diseases

Targeting Multidrug-Resistant Acinetobacter spp.: Sulbactam and the Diazabicyclooctenone β-Lactamase Inhibitor ETX2514 as a Novel Therapeutic Agent

(2019) Melissa D. Barnes et al.   mBio

Interplay between β-lactamases and new β-lactamase inhibitors

(2019) Karen Bush et al.   NATURE REVIEWS MICROBIOLOGY

Carbapenem-resistant Acinetobacterbaumannii: in pursuitof an effective treatment

(2019) Evangelia-Theophano Piperaki et al.   CLINICAL MICROBIOLOGY AND INFECTION

Pharmacokinetics, Safety, and Tolerability of Intravenous Durlobactam and Sulbactam in Subjects with Renal Impairment and Healthy Matched Control Subjects

(2019) John O'Donnell et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

In vitro activity of the novel fluorocycline TP-6076 against carbapenem-resistant Acinetobacter baumannii

(2019) Harald Seifert et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Global prevalence of colistin resistance in clinical isolates of Acinetobacter baumannii: A systematic review and meta-analysis

(2019) Ali Pormohammad et al.   MICROBIAL PATHOGENESIS

Molecular Epidemiology and Mechanism of Sulbactam Resistance in Acinetobacter baumannii Isolates with Diverse Genetic Backgrounds in China

(2018) Yunxing Yang et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

In-vitro activity of the novel fluorocycline eravacycline against carbapenem non-susceptible Acinetobacter baumannii

(2018) Harald Seifert et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis

(2018) Evelina Tacconelli et al.   LANCET INFECTIOUS DISEASES

Plasma and Intrapulmonary Concentrations of ETX2514 and Sulbactam following Intravenous Administration of ETX2514SUL to Healthy Adult Subjects

(2018) Keith A. Rodvold et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Predominance of international clone 2 OXA-23-producing- Acinetobacter baumannii clinical isolates in Greece, 2015: results of a nationwide study

(2017) Spyros Pournaras et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

High incidence of pandrug-resistant Acinetobacter baumannii isolates collected from patients with ventilator-associated pneumonia in Greece, Italy and Spain as part of the MagicBullet clinical trial

(2017) J Nowak et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

ETX2514 is a broad-spectrum β-lactamase inhibitor for the treatment of drug-resistant Gram-negative bacteria including Acinetobacter baumannii

(2017) Thomas F. Durand-Réville et al.   Nature Microbiology

Head-to-Head Comparison of Two Multi-Locus Sequence Typing (MLST) Schemes for Characterization of Acinetobacter baumannii Outbreak and Sporadic Isolates

(2016) Franziska Tomaschek et al.   PLoS One

Molecular Mechanisms of Sulbactam Antibacterial Activity and Resistance Determinants in Acinetobacter baumannii

(2015) William F. Penwell et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Fatal Outbreak of an Emerging Clone of Extensively Drug-ResistantAcinetobacter baumanniiWith Enhanced Virulence

(2015) Crystal L. Jones et al.   CLINICAL INFECTIOUS DISEASES

Task force on management and prevention of Acinetobacter baumannii infections in the ICU

(2015) José Garnacho-Montero et al.   INTENSIVE CARE MEDICINE

Inclusion of OXA-143 primers in a multiplex polymerase chain reaction (PCR) for genes encoding prevalent OXA carbapenemases in Acinetobacter spp.

(2009) Paul G. Higgins et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Global spread of carbapenem-resistant Acinetobacter baumannii

(2009) P. G. Higgins et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Acinetobacter baumannii: Emergence of a Successful Pathogen

(2008) A. Y. Peleg et al.   CLINICAL MICROBIOLOGY REVIEWS